Home/ Stocks/ XGN

Exagen Inc. Common Stock

XGN XNAS

$6.87 +0.28 (+4.25%) ▲ 15-min delayed

Open

$6.68

High

$6.94

Low

$6.48

Volume

431.9K

Market Cap

$159.64M

About Exagen Inc. Common Stock

Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.

Sector: SERVICES-MEDICAL LABORATORIES Employees: 220 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$19.94M	$-3,196,000	$-0.13
Q1 2026	$17.31M	$-3,967,000	$-0.17
FY 2025	$66.58M	$-19,951,000	$-0.93
Q3 2025	$17.24M	$-7,087,000	$-0.31

Earnings & Analyst Ratings

Next Earnings: Mon, Nov 2, 2026

Calendar →

Related Market News

No specific coverage for XGN yet. Check out our latest market news or earnings calendar.

Get XGN Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Exagen Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.